Oncogenic alterations of genes encoding members of the ERBB family, leading to unusual ERBB signaling and driving tumor growth, have been reported in different types of cancer, such as breast, lung, and gastrointestinal cancers. This evidence concerns the gene EGFR and neoplasm.